| IDA | 1) Imino-Diacetic Acid 2) Iron Deficiency Anemia Cause 1. Blood Loss(Pathologic Iron Loss); mc 1) Gastrointestinal Bleeding 2) Genitourinary Bleeding 3) Pulmonary Hemosiderosis 4) Intravascular Hemolysis 2. Increased Requirement(Iron Utilization) 1) Postnatal Growth Spurt 2) Adolescent Growth Spurt 3. Physiologic Iron Loss 1) Menstruation 2) Pregnancy 4. Inadequate Dietary Intake 1) Cereal-rich, Meat poor Diets 2) Food Faddists 3) Elderly & Indigent 5. Decreased Intestinal Absorption 1) Malabsorption |
|---|---|
| IDA | idamycin; image display and analysis; iminodiacetic acid; insulin-degrading activity; iron deficiency anemia |
| IDAV | immunodeficiency-associated virus |
| IDA | Idarubicin |
|---|---|
| IDA | Idazoxan |
| IDA | Iron Deficiency Anemia |
| IDA | iminodiacetate |
| IDA | iminodiacetic acid |
| IDA | <abbreviation> Iminodiacetate, whose derivatives are used in radiopharmaceuticals with a 99mTc label. See: HIDA. See: DISIDA. (05 Mar 2000) |
|---|---|
| idarubicin | <chemical> 3-acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy- 6,11-dioxo-1-naphthacenyl-3-amino-2,3,6-trideoxy- alpha-l-lyxo-hexapyranoside. An orally administered anthracycline antibiotic. The compound has shown activity against breast cancer, lymphomas and leukaemias, together with potential for reduced cardiac toxicity. Pharmacological action: antibiotics, anthracycline. Chemical name: 5,12-Naphthacenedione, 9-acetyl-7-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, (7S-cis)- (12 Dec 1998) |
| idazoxan | <chemical> An alpha(2)-adrenoceptor antagonist. It has been used experimentally to test the binding activity of other chemicals. Pharmacological action: adrenergic alpha-antagonists. (12 Dec 1998) |
Synonyms :
Synonyms : 4-Desmethoxydaunorubicin, IMI-30, Idarubicin Hydrochloride, NSC-256439, 4 Demethoxydaunorubicin, 4 Desmethoxydaunorubicin, Hydrochloride, Idarubicin, IMI 30, IMI30, NSC 256439, NSC256439
Synonyms : RX-781094, RX 781094, RX781094
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|---|---|---|---|
|
자베도스주5mg - 새창
|
Pharmacia |
E00130071 | Idarubicin HCl | 전문의약품 | 삭제 |
|
자베도스캅셀10mg - 새창
|
Pharmacia |
E00130181 | Idarubicin HCl | 전문의약품 | 삭제 |
|
자베루신주사 - 새창
|
한국유나이티드제약 |
A12955971 | Idarubicin HCl | 전문의약품 | 삭제 |
|
이다랄렘주5mg - 새창
|
Lemery, S.A. de C.V. |
A60850041 | Idarubicin HCl | 전문의약품 | 급여 |
|
아루비신주 - 새창
|
넥스팜코리아 |
A66352181 | Idarubicin HCl | 전문의약품 | 삭제 |
|
이다루주5mg - 새창
|
중외 |
A02151901 | Idarubicin HCl | 전문의약품 | 급여 |
|
자벤스주 - 새창
|
아남제약 |
A05350921 | Idarubicin HCl | 전문의약품 | 삭제 |
|
이루비신주 - 새창
|
광동제약 |
A22651991 | Idarubicin HCl | 전문의약품 | 삭제 |
|
자벨주사 - 새창
|
한림제약 |
A37851321 | Idarubicin HCl | 전문의약품 | 급여 |
|
이다빈주 - 새창
|
한국유니온제약 |
A12253931 | Idarubicin HCl | 전문의약품 | 삭제 |
| IDA |
iminodiacetic acid.
출처: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
|---|---|
| Idamycin |
trademark for a preparation of idarubicin hydrochloride.
출처: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
| idarubicin hydrochloride |
[USP] an anthracycline antineoplastic used in the treatment of acute myelogenous leukemia; administered intravenously.
출처: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
| IDA | an agency of the United Nations affiliated with the World Bank |
|---|---|
| IDA | a state in the Rocky Mountains |
| IDA | a town in southeastern Idaho on the Snake River |
| IDA | a resident of Idaho |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
